ENVOY MEDICAL, INC. (COCH) Operating Margin
- Operating margin · 12 months: Value -11411.11%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -11411.11% | Operating income / revenue. Period ending 2026-06-30. $-23.62M ÷ $207.00K × 100 ≈ -11411.11% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -23.62M USD | Operating Income (Loss) |
| Revenue | 207.00K USD | |
| Cost of products and services | 1.00M USD | Cost of Goods and Services Sold |
| Research and development | 14.03M USD | Research and Development Expense |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-23.62M | $207.00K | $1.00M | $14.03M | (m) | -11411.11% |
| 2026-03-31 | $-23.12M | $234.00K | $961.00K | $13.38M | (m) | -9881.20% |
| 2025-12-31 | $-22.27M | $241.00K | $874.00K | $12.49M | (m) | -9240.66% |
| 2025-09-30 | $-20.43M | $208.00K | $820.00K | $10.40M | (m) | -9824.04% |
| 2025-06-30 | $-19.70M | $222.00K | $804.00K | $10.46M | (m) | -8872.97% |
| 2025-03-31 | $-19.48M | $212.00K | $815.00K | $10.57M | (m) | -9188.21% |
| 2024-12-31 | $-19.26M | $225.00K | $742.00K | $10.18M | (m) | -8558.22% |
| 2024-09-30 | $-21.47M | $278.00K | $819.00K | $10.76M | (m) | -7721.94% |
| 2024-06-30 | $-19.88M | $302.00K | $850.00K | $9.83M | (m) | -6582.12% |
| 2024-03-31 | $-19.50M | $297.00K | $767.00K | $9.39M | (m) | -6564.98% |
| 2023-12-31 | $-18.37M | $316.00K | $789.00K | $8.96M | $7.28M | -5813.61% |
| 2023-09-30 | $-10.72M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $-5.09M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $-5.89M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-4.89M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $-4.39M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $-6.34M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $-5.73M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-5.20M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |